MedTrace Logo

A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection

NCT06322875 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2024-03-21

No results posted yet for this study

Summary

To evaluate the efficacy and safety of recombinant humanized collagen (type III) solution for injection combined with SkinCeuticals recombinant humanized collagen (RHC) serum Participants will be assessed by subjective questionnaire (FACE-Q Satisfaction with skin,Global Aesthetic Improvement Scale, et al) and some medical instruments (VISIA,Ultrascan UC22 et al)

Conditions

  • Facial Wrinkles

Interventions

PROCEDURE

Recombinant type III humanized collagen solution for injection

Each subject will receive one injection of Recombinant type III humanized collagen solution for injection on the whole face

OTHER

SkinCeuticals recombinant humanized collagen (RHC) serum

Subjects received SkinCeuticals recombinant humanized collagen (RHC) serum application on the test side face

OTHER

Regular face cream smear

Subjects received Regular face cream smear application on the whole face

Sponsors & Collaborators

  • DeYi Aesthetic Medical Clinic

    lead OTHER

Principal Investigators

  • Xiaolei Qin · DeYi Aesthetic Medical Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-31
Primary Completion
2024-07-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322875 on ClinicalTrials.gov